{"url_path":"/sec/vbio/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 **","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1787740/0001437749-26-017142-index.html","accession_number":"0001437749-26-017142","cik":"0001787740","ticker":"VBIO","issuer_name":"Tivic Health Systems, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1787740/0001437749-26-017142-index.html","primary_entity_key":"0001787740","primary_entity_name":"Valion Bio, Inc."},"word_count":63,"has_tables":true,"body_markdown":"**Item 2.**\n\n**Unregistered Sales of Equity Securities and Use of Proceeds**\n\n \n\n*Recent Sales of Unregistered Securities*\n\n \n\nDuring the quarter ended March 31, 2026, there were no unregistered sales of our securities that were not disclosed in a Current Report on Form 8-K.\n\n \n\n*Repurchases*\n\n \n\nThe Company did not repurchase any of the Company’s outstanding equity securities during the three months ended March 31, 2026."}